Information de reference pour ce titreAccession Number: | 00002300-200607000-00002.
|
Author: | Krengel, S.; Hauschild, A. *; Schafer, T. +
|
Institution: | Department of Dermatology, Medical University Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany (Krengel) (*)Department of Dermatology, University of Kiel, Kiel, Germany +Institute of Social Medicine, University of Lubeck, Lubeck, Germany
|
Title: | |
Source: | British Journal of Dermatology. 155(1):1-8, July 2006.
|
Abstract: | Background: The risk of malignant melanoma in congenital melanocytic naevi (CMN) is a matter of controversial and ongoing debate.
Objectives: The purpose of this systematic review is to provide a careful and detailed summary of the published data, including several recently published studies.
Methods: Articles on CMN (n = 1424) were retrieved from Medline, 1966-October 2005. Case reports and studies lacking relevant clinical information were excluded. Only systematic collections of cases were taken into consideration. Series with fewer than 20 patients or studies with a mean follow-up of <3 years were regarded as epidemiologically less significant.
Results: Fourteen articles were finally chosen for further analysis. The studies varied significantly with respect to study design (source of cases; retrospective vs. prospective analysis), age of patients, follow-up time, and naevus characteristics. The frequency of melanomas ranged between 0[middle dot]05% and 10[middle dot]7% and was significantly higher in smaller studies (P < 0[middle dot]0001). In a total of 6571 patients with CMN who were followed for a mean of 3[middle dot]4-23[middle dot]7 years, 46 patients (0[middle dot]7%) developed 49 melanomas. The mean age at diagnosis of melanoma was 15[middle dot]5 years (median 7). By comparison with age-adjusted data from the Surveillance, Epidemiology and End Results database, we calculated that patients with CMN carry an approximately 465-fold increased relative risk of developing melanoma during childhood and adolescence. Primary melanomas arose inside the naevi in 33 of 49 cases (67%). In seven cases (14%), metastatic melanoma with unknown primary was encountered; in four cases (8%) the melanoma developed at an extracutaneous site. The risk of developing melanoma and the rate of fatal courses were by far highest in CMN >=40 cm in diameter.
Conclusions: The overall risk of melanoma of 0[middle dot]7% in all 14 studies was lower than expected. The higher incidence of melanomas in smaller studies indicates selection bias. The melanoma risk strongly depends on the size of CMN and is highest in those naevi traditionally designated as garment naevi. The median age of 7 years at diagnosis of melanoma points to a risk maximum in childhood and adolescence. Future studies on CMN should report: (i) diameter, percentage of body surface, and localization of the CMN; (ii) percentage of naevus area removed by excision or subject to dermabrasion or other superficial treatments; (iii) mean and median age at entry into the study; (iv) mean and median follow-up time; (v) details on each melanoma case; (vi) standardized morbidity ratio of melanoma; and (vii) percentage of neurocutaneous melanosis.
(C) 2006 British Association of Dermatologists
|
Author Keywords: | congenital naevus; epidemiology; malignant melanoma; risk.
|
References: | 1 Krengel S. Nevogenesis - new thoughts regarding a classical problem. Am J Dermatopathol 2005; 27:456-65.
2 Torrelo A, Baselga E, Nagore E et al. Delineation of the various shapes and patterns of nevi. Eur J Dermatol 2005; 15:439-50.
3 Zaal LH, Mooi WJ, Sillevis Smitt JH et al. Classification of congenital melanocytic naevi and malignant transformation: a review of the literature. Br J Plast Surg 2004; 57:707-19.
4 Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979; 1:123-30.
5 DeDavid M, Orlow SJ, Provost N et al. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 1996; 35:529-38.
6 Bittencourt FV, Marghoob AA, Kopf AW et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 2000; 106:736-41.
7 Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol 2005; 52:793-7.
8 Berg P, Lindelof B. Congenital melanocytic naevi and cutaneous melanoma. Melanoma Res 2003; 13:441-5.
9 Rivers JK, Frederiksen PC, Dibdin C. A prevalence survey of dermatoses in the Australian neonate. J Am Acad Dermatol 1990; 23:77-81.
10 Ka VS, Dusza SW, Halpern AC et al. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an internet-based registry of 379 patients. Melanoma Res 2005; 15:61-7.
11 Hale EK, Stein J, Ben-Porat L et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi - results from the NYU-LCMN registry. Br J Dermatol 2005; 152:512-17.
12 Castilla EE, da Graca Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 1981; 104:307-15.
13 Pack GT, Davis J. Nevus giganticus pigmentosus with malignant transformation. Surgery 1961; 49:347-54.
14 Pers M. Naevus pigmentosus giganticus. Ugeskr Laeger 1963; 125:613-19.
15 Kaplan EN. The risk of malignancy in large congenital nevi. Plast Reconstr Surg 1974; 53:421-8.
16 Rhodes AR, Wood WC, Sober AJ et al. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 1981; 67:782-90.
17 Watt AJ, Kotsis SV, Chung KC. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 2004; 113:1968-74.
18 Lorentzen M, Pers M, Bretteville-Jensen G. The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg 1977; 11:163-7.
19 Arons MS, Hurwitz S. Congenital nevocellular nevus: a review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg 1983; 72:355-65.
20 Dawson HA, Atherton DJ, Mayou B. A prospective study of congenital melanocytic naevi: progress report and evaluation after 6 years. Br J Dermatol 1996; 134:617-23.
21 Greeley PW, Middleton GA, Curtin JW. Incidence of malignancy in giant pigmented nevi. Plast Reconstr Surg 1965; 36:26-37.
22 Quaba AA, Wallace AF. The incidence of malignant melanoma (0 to 15 years of age) arising in 'large' congenital nevocellular nevi. Plast Reconstr Surg 1986; 78:174-81.
23 Gari LM, Rivers JK, Kopf AW. Melanomas arising in large congenital nevocytic nevi: a prospective study. Pediatr Dermatol 1988; 5:151-8.
24 Ruiz-Maldonado R, Tamayo L, Laterza AM et al. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr 1992; 120:906-11.
25 Swerdlow AJ, English JS, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 1995; 32:595-9.
26 Marghoob AA, Schoenbach SP, Kopf AW et al. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 1996; 132:170-5.
27 Sahin S, Levin L, Kopf AW et al. Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol 1998; 39:428-33.
28 Egan CL, Oliveria SA, Elenitsas R et al. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol 1998; 39:923-32.
29 Foster RD, Williams ML, Barkovich AJ et al. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 2001; 107:933-41.
30 DeDavid M, Orlow SJ, Provost N et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997; 36:409-16.
31 Ries LAG, Eisner MP, Kosary CL et al. (eds) SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute, 2005 ( http://seer.cancer.gov/csr/1975_...- ouverture dans une nouvelle fenêtre, based on November 2004 SEER data submission, posted to the SEER website 2005).
32 Leman JA, Evans A, Mooi W et al. Outcomes and pathological review of a cohort of children with melanoma. Br J Dermatol 2005; 152:1321-3.
33 Kinsler VA, Aylett SE, Coley SC et al. Central nervous system imaging and congenital melanocytic nevi. Arch Dis Child 2001; 84:152-5.
34 Marghoob AA, Dusza S, Oliveria S et al. Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 2004; 140:171-5.
35 Ruiz-Maldonado R. Measuring congenital melanocytic nevi. Pediatr Dermatol 2004; 21:178-9.
|
Language: | English.
|
Document Type: | Review article.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0007-0963
|
NLM Journal Code: | aw0, 0004041
|
Annotation(s) | |
|
|